The Structural Genomics Consortium at the Goethe University Frankfurt (SGC Frankfurt) is focussed on the development and rational design of selective inhibitors (chemical probes) targeting key signalling molecules and their use for the validation of new targets. The research team focusses on three main key areas:
The SGC Frankfurt is also coordinating the susanne.mueller-knapp[at]bmls.de (pharma probe project) a project that makes high quality probes developed for different therapeutic areas that are no longer pursued as drug candidates or leads in pharma companies available to the public.
The team has capacities for protein production, in vitro screening (biochemical and biophysical methods as well as cell-based assays) and X-ray crystallography.
The SGC Frankfurt is housed at the Buchmann Institute for Molecular Life Sciences. Scientists at the SGC Frankfurt are associated with the Faculty “Biochemistry, Chemistry and Pharmacy".